Priority Date: 19.07.12 (FR 20120057021)

USE OF EPIGENOME-MODIFYING COMPOUNDS FOR THE TREATMENT OF GENETIC MUSCULAR DISEASES LINKED TO A PROTEIN-CONFORMATIONAL DISORDER

  • Application ID: EP13744754
  • Status: GRANT OF PATENT INTENDED

Attorney

Employment test 11 - 50 employees
Company dna cabinet laurent and charras
no operation time available
Headquarter in Lyon and 5 offices
active in Legal Services and IP Consulting

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and G01 (MEASURING; TESTING) is specialized in the combination A61 and G01. We found, that Coller IP Management Ltd, TransMIT GmbH, Kailuweit & Uhlemann, Bock Bieber Donath, Dr. Emil Benatov & Partners - Bulgarian Patent Attorney & Licensed Appraiser and 173 others are specialized in all of these IPC classes. For a similar patent, they might be a good choice.

Timeline

  • 19.07.2012 - Priority Date (FR 20120057021)
  • 23.01.2014 - Publication A1 (WO2014013184)
  • 27.05.2015 - Publication A1 (EP2874618)

IPC Classification